Register or Sign in to Save this opportunity, or Send an Inquiry.
Seeking to in-license Late Stage Prescription Products Into the Nordic Region
Leiras Takeda Pharmaceuticals Finland flag Finland
Abstract ID:
Phase III and beyond prescription products are sought to in-license into the four major Nordic countries.
Send an Inquiry

Leiras Finland is seeking late stage (phase III onwards) prescription products in the following therapeutic indications; respiratory diseases, pain management, oncology diseases, cardiovascular health and metabolic diseases.

The company wishes to in-license the products into the four major Nordic countries. Any drugs to be considered should adhere to the following requirements;

1) Should have undergone phase II clinical trials, be NDA ready/submitted or marketing authorization
2) Should not require participation from Takeda/ commitment on new Clinical Trials
3) Serves an unmet medical need
4) Has patent coverage available for many years
5) Is directed mainly to a specialist
6) Be delivered in complete final packages and undergo release in the EU by a supplier



Type of Business Relationship Sought

Leiras Finland is looking to in-license any potential candidates.

Last Updated Jul 2014
Technology Type
Phase of Development CLINICAL TRIALS

Opportunity Contact